DIR Return Create A Forum - Home
---------------------------------------------------------
Road2HardCoreIron
HTML https://road2hardcoreiron.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: HGH/ IGF1/ SLIN & Peptides
*****************************************************
#Post#: 5139--------------------------------------------------
CANADAPEPTIDEBIOLAB 10 ML Bac Water Included
By: Road2HardCoreIron Date: June 14, 2024, 6:51 pm
---------------------------------------------------------
Learn how Somatropin 191aa works and what you can expect from
therapy, including safety concerns, possible risk factors, and
known side effects.
How is it given?
Yes, growth hormone therapy is given by injection, but don’t let
that scare you—or your child.
All Canada Peptides products should be kept cool prior to first
use. Do not freeze. After dissolving, Somatropin 191aa in the
refrigerator (between 36°F and 46°F [2°C and 8°C]) for use
within 1-2 weeks.
More than the medicine.
All FDA-approved human growth hormone products are similar:
they’re identical to the growth hormone your body makes. But
growth hormone therapy is about more than just the medicine.
It’s also about how that medicine is given and how the company
supports their patients.
Not Just For Kids
Growth hormone deficiency affects adults, too
Important Risk Information and Indication
You Should not take Somatropin 191aa [somatropin (rDNA origin)
if you have:
A critical illness due to complications after open heart
surgery, abdominal surgery, serious injuries or have severe
breathing problems
Cancer or undergoing treatment for cancer
Certain types of eye diseases caused by diabetes
Allergies to growth hormone or benzyl alcohol, an ingredient in
the liquid used to mix Somatropin 191aa
What should I tell my healthcare provider before using
Somatropin 191aa? Before using Somatropin 191aa, tell your
doctor if you have or are:
A critical illness due to complications after open heart
surgery, abdominal surgery or serious injuries or have severe
breathing problems
Cancer or history of cancer
Skin lesions
Diabetes, a family history of diabetes or have been told by your
doctor that you are at risk for diabetes
Multiple hormone deficiencies
Pregnant or nursing
Taking any medications, especially cyclosporine, hormone
replacement therapy, insulin or other diabetes medications,
drugs containing steroids, or drugs for seizure
Liver or kidney disease
Over 65 years of age
Have any other medical condition
What are the possible side effects of Somatropin 191aa?
Somatropin 191aa may cause serious side effects including:
Concomitant Antiretroviral Therapy:
In some experimental systems, somatropin has been shown to
increase HIV replication in vitro. Because of this possibility
for acceleration of virus replication, it is recommended that
you continue on your antiretroviral therapy for the duration of
Somatropin 191aa treatment.
Impaired Glucose Tolerance/Diabetes:
Cases of new onset impaired glucose tolerance (pre-diabetes),
new onset type 2 diabetes mellitus and worsening of current
diabetes mellitus have been reported in patients receiving
Somatropin 191aa. Some patients developed diabetic complications
(ketoacidosis and diabetic coma). In some patients, these
conditions improved when Somatropin 191aawas discontinued, while
in others, the glucose intolerance persisted.
Intracranial Hypertension:
Intracranial hypertension, a rise in the pressure inside the
skull, associated visual changes, headache, nausea, and/or
vomiting has been reported.
Fluid Retention/Carpal Tunnel Syndrome:
Water retention may occur in adults during Somatropin
191aatherapy. Increased swelling, particularly in the hands and
feet, muscle or joint pain may occur during treatment with
Somatropin 191aa. Often these reactions resolve with analgesic
therapy, or after decreasing the number of doses.
Carpal tunnel syndrome may occur during treatment with
Somatropin 191aaIf the symptoms of carpal tunnel syndrome do not
resolve by decreasing the weekly number of doses of Somatropin
191aa, it is recommended that treatment be discontinued.
Kaposi's sarcoma, Lymphoma and other Malignancies:
Kaposi's sarcoma (KS), lymphoma, and other malignancies are more
common in HIV+ individuals. There was no increase in the
incidence of Kaposi's sarcoma, lymphoma, or in the progression
of cutaneous Kaposi's sarcoma in clinical studies of Serostim®.
Patients with internal KS lesions were excluded from the
studies. Potential effects on other malignancies are unknown.
Local and Systemic Reactions:
Injection sites should be changed (rotated) to avoid tissue
atrophy. Patients should be informed that local and systemic
reactions are possible and that prompt medical attention should
be sought if allergic reactions occur.
Pancreatitis:
Inflammation of the pancreas has been reported rarely in adults
receiving growth hormone.
The most common side effects of Somatropin 191aa include:
In clinical trials the most common adverse reactions included
swelling (particularly of the hands or feet), muscle pain, joint
pain, numbness, and pain in extremities.
Injection site reactions (pain, numbness, redness, swelling).
Change (rotate) your injection site to help lower your risk for
injection site reactions.
Fluid retention
Bone, joint or muscle pain
Swelling of the extremities
Carpal tunnel syndrome
Breast enlargement
Nausea
Fatigue
Increase in blood glucose
Increase in triglycerides
*****************************************************